Blue Trust’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Blue Trust's REGN Position: Q3 2026 in Review
Blue Trust reduced its Regeneron Pharmaceuticals (REGN) stake by 19% in Q3 2026, selling an estimated $126K and leaving 692 shares worth $525K. The position accounts for 0.01% of the portfolio, ranked #464.
Blue Trust first reported a position in REGN in Q2 2022 and has held it in 18 quarters since. The position peaked at $596K in Q1 2026. 1,212 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Blue Trust held 692 shares of Regeneron Pharmaceuticals worth $525K as of Q3 2026.
- Blue Trust sold 167 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $126K.
- Regeneron Pharmaceuticals made up 0.01% of Blue Trust's portfolio in Q3 2026, its #464 holding.
- Blue Trust first reported a position in Regeneron Pharmaceuticals in Q2 2022 and has held it in 18 quarters since.
- Blue Trust's Regeneron Pharmaceuticals position peaked at $596K in Q1 2026.
- 1,212 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.